We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine

By LabMedica International staff writers
Posted on 16 Jan 2024
Print article
Image: NextGen Medicine will be a key topic at the 2024 edition of Medlab Middle East (Photo courtesy of Informa Markets)
Image: NextGen Medicine will be a key topic at the 2024 edition of Medlab Middle East (Photo courtesy of Informa Markets)

Some of the most prominent researchers in the field of NextGen medicine are expected to gather at the 2024 edition of Medlab Middle East, the region’s largest medical laboratory exhibition organized by Informa Markets Healthcare (London, UK). In collaboration with Express Med Diagnostics and Research (Manama, Bahrain), Medlab Middle East will be held from 5 to 8 February. This year, Medlab Middle East will welcome more than 30,000 visitors and 900 exhibitors, with representation from 180 countries. Tracks at the event include Laboratory Management, Hematology, Quality Management, Clinical Microbiology, Histopathology, Clinical Chemistry, Clinical Genomic Interpretation, Future of the Lab, Immunology, Blood Transfusion Medicine, and Sustainability in the Lab. The Medlab Middle East Congress will return for yet another year, providing education and solutions to advance laboratory skills to over 5,000 delegates.

NextGen medicine is a cutting-edge field of healthcare that utilizes genome sequencing to create targeted healthcare strategies for specific populations and individuals for a variety of diseases and rare conditions. The 'genome' is defined as the complete set of DNA instructions in a cell, which holds all the information required for the development and functioning of an individual. In 2003, the Human Genome Project successfully developed the first complete sequence of the human genome, leading to one of the most transformative breakthroughs in science and healthcare. Genome projects targeting specific national populations are currently underway in various regions across the Middle East. Interestingly, researchers are observing differences in DNA even within those national populations.

For instance, in Oman, researchers have found that individuals native to Salalah possess a completely distinct pool of mutations in comparison to people with ancestry from Muscat or Musandam. In March 2023, the UAE launched a 10-year National Genome Strategy to aid the development and implementation of genomic research projects and improve public health priorities in the UAE. The project focuses on accelerating developments in personalized medicine and combating chronic and genetic diseases. The Emirati Genome Program, the founding project of the UAE’s National Genome Strategy, will use cutting-edge DNA sequencing and artificial intelligence to examine the genetic profile of Emiratis.

“There are three key components of NextGen medicine – prevention, early detection, and the development of targeted treatments. The future of medicine is all about moving away from a 'one size fits all' approach to more personalized health strategies. It is essential that screening strategies are adjusted to the local reality as this will ultimately save lives, improve health outcomes, and reduce the costs associated with ineffective treatments,” said Dr. Karolina Kobus, Head of Genomics and Precision Medicine Lab Technology and Innovation Advisor at Express Med Diagnostics and Research. “Genomic inheritance is unique for every population and this means that disease patterns will differ in a Caucasian individual compared with those native to the Middle East for example. While significant progress has been made in genome projects in the Western world, we must acknowledge that the current human genome that is widely referenced is mainly based on data from Caucasian individuals.”

“The Middle East genome projects have the potential to contribute significantly to global science and improve healthcare in the region. This field of study is extremely promising, and the findings could lead to major advancements in the treatment of various illnesses, such as diabetes, heart disease, and cancer,” added Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “Medlab’s partnership with Express Med Diagnostics and Research at Medlab Middle East will showcase the latest advancements in medical technology precision diagnostics and medical laboratory solutions. Chaired by Dr. Karolina Kobus, the NextGen Medicine Conference will bring together top industry experts, researchers, and healthcare professionals who are driving innovations forward. The conference will share the latest updates on regional genome projects and delve into pressing topics such as early cancer detection, precision oncology, preventative health screening, and longevity.”

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Dengue Virus Test
LINEAR Dengue-CHIK

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: The new DxC 500i Clinical Analyzer is an integrated clinical chemistry and immunoassay analyzer (Photo courtesy of Beckman Coulter Diagnostics)

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability

As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more

Molecular Diagnostics

view channel
Image: Schematic illustration of the SEDphone system workflow (Photo courtesy of ZHU Cancan)

Smartphone-Controlled Microfluidic Device Enables Rapid Influenza Detection

The influenza virus represents a significant public health concern, annually causing epidemics with high morbidity and mortality rates. The virus is known for its high mutation rate and the existence of... Read more

Hematology

view channel
Image: The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) (Photo courtesy of HORIBA)

New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds

HORIBA (Kyoto, Japan) has expanded its line of compact hematology analyzers by introducing new models that incorporate Erythrocyte Sedimentation Rate (ESR) measurement capabilities. The newly launched... Read more

Pathology

view channel
Image: High-speed brightfield scanners offer excellent image quality to aid pathologists\' review of digital slides (Photo courtesy of Roche)

Whole-Slide Imaging System Enables Pathologists to Diagnose Patients Using Digital Images

Digital pathology involves the digitalization of the traditional pathology workflow, starting from slide scanning to visualization, to analysis. Digital pathology is transforming traditional histopathology... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.